» Articles » PMID: 38487712

Macrophage Exosomes Modified by MiR-365-2-5p Promoted Osteoblast Osteogenic Differentiation by Targeting OLFML1

Overview
Journal Regen Biomater
Date 2024 Mar 15
PMID 38487712
Authors
Affiliations
Soon will be listed here.
Abstract

In the bone immune microenvironment, immune cells can regulate osteoblasts through a complex communication network. Macrophages play a central role in mediating immune osteogenesis, exosomes derived from them have osteogenic regulation and can be used as carriers in bone tissue engineering. However, there are problems with exosomal therapy alone, such as poor targeting, and the content of loaded molecules cannot reach the therapeutic concentration. In this study, macrophage-derived exosomes modified with miR-365-2-5p were developed to accelerate bone healing. MC3T3-E1 cells were incubated with the culture supernatants of M0, M1 and M2 macrophages, and it was found that the culture medium of M2 macrophages had the most significant effects in contributing to osteogenesis. High-throughput sequencing identified that miR-365-2-5p was significantly expressed in exosomes derived from M2 macrophages. We incubated MC3T3-E1 with exosomes overexpressing or knocking down miR-365-2-5p to examine the biological function of exosome miR-365-2-5p on MC3T3-E1 differentiation. These findings suggested that miR-365-2-5p secreted by exosomes increased the osteogenesis of MC3T3-E1. Moreover, miR-365-2-5p had a direct influence over osteogenesis for MC3T3-E1. Sequencing analysis combined with dual luciferase detection indicated that miR-365-2-5p binded to the 3'-UTR of OLFML1. In summary, exosomes secreted by M2 macrophages targeted OLFML1 through miR-365-2-5p to facilitate osteogenesis.

Citing Articles

Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins.

Chen Y, Qi W, Wang Z, Niu F Pharmaceutics. 2025; 17(2).

PMID: 40006514 PMC: 11858990. DOI: 10.3390/pharmaceutics17020147.


Fused extracellular vesicles from M macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis.

Liu Q, Ma T, Zhang Z, Nan J, Liu G, Yang Y J Extracell Vesicles. 2024; 13(12):e70028.

PMID: 39711510 PMC: 11664327. DOI: 10.1002/jev2.70028.


M2 macrophage-derived exosomes enable osteogenic differentiation and inhibit inflammation in human periodontal ligament stem cells through promotion of CXCL12 expression.

Gao J, Wu Z BMC Oral Health. 2024; 24(1):1070.

PMID: 39261847 PMC: 11391719. DOI: 10.1186/s12903-024-04831-4.

References
1.
Zhu Y, Zhao S, Cheng L, Lin Z, Zeng M, Ruan Z . Mg -mediated autophagy-dependent polarization of macrophages mediates the osteogenesis of bone marrow stromal stem cells by interfering with macrophage-derived exosomes containing miR-381. J Orthop Res. 2021; 40(7):1563-1576. DOI: 10.1002/jor.25189. View

2.
Suh J, Lee J, Choi Y, Chung C, Chong P, Park Y . Peptide-mediated intracellular delivery of miRNA-29b for osteogenic stem cell differentiation. Biomaterials. 2013; 34(17):4347-59. DOI: 10.1016/j.biomaterials.2013.02.039. View

3.
Hu L, Xie X, Xue H, Wang T, Panayi A, Lin Z . MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2. Exp Mol Med. 2022; 54(7):961-972. PMC: 9355958. DOI: 10.1038/s12276-022-00799-9. View

4.
Rahimian N, Nahand J, Hamblin M, Mirzaei H . Exosomal MicroRNA Profiling. Methods Mol Biol. 2022; 2595:13-47. DOI: 10.1007/978-1-0716-2823-2_2. View

5.
Iaquinta M, Lanzillotti C, Mazziotta C, Bononi I, Frontini F, Mazzoni E . The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. Theranostics. 2021; 11(13):6573-6591. PMC: 8120225. DOI: 10.7150/thno.55664. View